ijms-logo

Journal Browser

Journal Browser

Gluten/Wheat-Related Disorders: The Role of Nutrition, Gut Barrier, Microbiota, and New Therapeutic Strategies

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 June 2025) | Viewed by 689

Special Issue Editor


E-Mail Website
Guest Editor
1. Arcispedale Sant'Anna, Azienda Ospedaliero-Universitaria di Ferrara Via Aldo Moro, 8 Cona, 44124 Ferrara, Italy
2. Policlinico Paolo Giaccone, Via del Vespro 129, 90127 Palermo, Italy
Interests: celiac disease; nutrition; non-celiac gluten/wheat sensitivity; irritable bowel syndrome; inflammatory bowel diseases; molecular biology; Fabry disease

Special Issue Information

Dear Colleagues,

Gluten-related disorders (GRDs) include distinct conditions, specifically celiac disease (CD), wheat allergy (WA), and non-celiac gluten/wheat sensitivity (NCGWS).

The gut microbiome plays a vital role in immune regulation, and alterations in its composition may be associated with GRDs, including CD. Certain bacteria might enhance immune responses by mimicking gliadin or exacerbating intestinal inflammation with gluten. The microbiome also affects the development of antigens, intestinal permeability, and the production of pro-inflammatory or anti-inflammatory cytokines. Genetic predispositions and early life experiences significantly shape the initial gut microbiome.

Disruptions in the epithelial barrier have also been observed across all three of these clinical conditions. However, its potential role as a pathogenetic co-factor—especially in CD and NCGWS—remains under investigation.

Currently, the sole effective treatment for CD is a stringent GFD. However, some patients continue to experience symptoms and exhibit partial villus atrophy due to gluten exposure, indicating that the GFD may not fully manage symptoms. Emerging therapeutic strategies being explored include gluten proteolysis, removal of gluten from the digestive system, promotion of tight junction integrity, inhibition of transglutaminase 2, utilization of probiotics, and immunotherapy.

This Special Issue of IJMS aims to showcase the latest developments in GFD for CD and other GRDs from a comprehensive viewpoint. It covers areas such as diet and nutrition, innovative techniques for gluten analysis, evaluation of gut barrier integrity, case reports featuring molecular-level data analysis, and complementary or alternative treatments, such as gluten-free wheat flours, probiotics, and medications.

Dr. Lisa Lungaro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gluten-related disorders
  • celiac disease
  • non celiac gluten wheat sensitivity
  • gluten free diet
  • microbiota
  • gut barrier
  • probiotics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

9 pages, 350 KiB  
Brief Report
Uncovering Hidden Gluten Exposure in Celiac Patients: A Case Study in Family-Based Management and the Role of Point-of-Care Urine Testing and Psychological Assessment
by Ángela Ruiz-Carnicer, Cristóbal Coronel-Rodríguez, María Cinta Guisado-Rasco, Isabel Comino, Carolina Sousa and Verónica Segura
Int. J. Mol. Sci. 2025, 26(11), 5135; https://doi.org/10.3390/ijms26115135 - 27 May 2025
Viewed by 531
Abstract
Celiac disease (CD) is a chronic immune-mediated enteropathy that requires strict adherence to a gluten-free diet (GFD) to prevent intestinal damage. Traditional methods for monitoring GFD adherence, such as serology and dietary assessments, often poorly correlate with histological findings and typically involve a [...] Read more.
Celiac disease (CD) is a chronic immune-mediated enteropathy that requires strict adherence to a gluten-free diet (GFD) to prevent intestinal damage. Traditional methods for monitoring GFD adherence, such as serology and dietary assessments, often poorly correlate with histological findings and typically involve a waiting period before results are available, limiting their usefulness for immediate clinical decision-making. This cross-sectional case study reports on a 45-year-old mother and her 11-year-old twin daughters, all diagnosed with CD and following a GFD for over two years. Despite being asymptomatic and showing negative anti-tTG serology, the mother continued to present Marsh 1 histological lesions, suggesting ongoing subclinical inflammation. Point-of-care testing (POCT) for gluten immunogenic peptides (GIP) in urine revealed positive results for all three individuals, indicating recent gluten exposure despite reported dietary adherence. A follow-up GIP test after dietary review and reinforcement yielded negative results, confirming improved adherence. Additionally, a psychological assessment using the Hospital Anxiety and Depression Scale (HADS) revealed anxiety symptoms in the mother and one of the daughters, which may have influenced adherence to the GFD. These findings underscore the clinical value of urinary GIP POCT as a rapid, non-invasive tool for detecting hidden gluten exposure, even when traditional monitoring appears normal. Integrating GIP testing and psychological screening into routine clinical practice may enhance management and support timely, personalized interventions in patients with CD. Full article
Show Figures

Graphical abstract

Back to TopTop